Skip to Content

Amgevita

Licence status
Authorised:
Active substances
Adalimumab
Dosage Form
Solution for injection
Licence number
EU/1/16/1164/002-009
Licence holder
Amgen Europe B.V.

Licence information

ATC code
L04AB Tumor necrosis factor alpha (TNF-) inhibitors, L04AB04 adalimumab
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie